Global Huntington's Disease Therapeutics Market Report 2021: Market to Reach $3.1 Billion by 2027 - U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Huntington's Disease Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Huntington's Disease Therapeutics Market to Reach $3.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Huntington's Disease Therapeutics estimated at US$402.2 Million in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 33.7% over the period 2020-2027.

The U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR

The Huntington's Disease Therapeutics market in the U.S. is estimated at US$107.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821 Million by the year 2027 trailing a CAGR of 41.6% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.9% and 30.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 28.9% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 25 Featured):

• Alnylam Pharmaceuticals, Inc.
• Evotec AG
• GlaxoSmithKline PLC
• Horizon Therapeutics plc
• Ionis Pharmaceuticals, Inc.
• Raptor Pharmaceutical Corporation
• Sangamo Biosciences, Inc.
• Suven Life Sciences Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Inc.
• Wave Life Sciences Ltd.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• World Current & Future Analysis for Huntington's Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
• World Historic Review for Huntington's Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
• World 15-Year Perspective for Huntington's Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

• United States
• Canada
• Japan
• China
• Europe
• France
• Germany
• Italy
• United Kingdom
• Spain
• Russia
• Rest of Europe
• Asia-Pacific
• Australia
• India
• South Korea
• Rest Of Asia-Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East
• Iran
• Israel
• Saudi Arabia
• United Arab Emirates
• Rest of Middle East
• Africa

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/wiwg4x

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900